Clinical Research Directory
Browse clinical research sites, groups, and studies.
COVID-19 Reactogenicity
Sponsor: Marcel Curlin
Summary
The purpose of this study is to compare post-vaccination reactions between the protein-based Novavax vaccine and the mNEXSPIKE mRNA-1283 vaccine. Specifically, the study aims to determine the rate of participant-reported symptoms associated with each type of vaccine.
Official title: Reactogenicity, Patient Reported Outcomes and Vaccine Preference in Adults Immunized With Recombinant Protein or mRNA COVID-19 Vaccines
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1000
Start Date
2025-10-01
Completion Date
2026-06-14
Last Updated
2026-03-04
Healthy Volunteers
Yes
Conditions
Interventions
Nuvaxovid (NVX-CoV2705)
COVID-19 vaccination
mNEXSPIKE mRNA-1283
COVID-19 vaccination
Locations (1)
Oregon Health and Sciences University
Portland, Oregon, United States